NEVVI Medicare utilization intelligence

← back

THOMAS, ERICMD NPI 1881915940 Clinician

Gynecological Oncology · OKLAHOMA CITY, OK

Specialty Gynecological Oncology — from billed Medicare claims
Trained UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 16 years since medical school (class of 2010, self-reported to CMS)
Location OKLAHOMA CITY, OK · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 58 codes billed · 67,503 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC
2019–2026
STILLWATER MEDICAL CENTER AUTHORITY
2019–2022

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2010-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1439 Injection, ferric carboxymaltose, 1 mg
J9267 Injection, paclitaxel, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9299 Injection, nivolumab, 1 mg
J1627 Injection, granisetron, extended-release, 0.1 mg
J0185 Injection, aprepitant, 1 mg
Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J1453 Injection, fosaprepitant, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J9045 Injection, carboplatin, 50 mg
80053 Blood test, comprehensive group of blood chemicals
83615 Lactate dehydrogenase (enzyme) level
83735 Magnesium level
84100 Phosphate level
84550 Uric acid level, blood
J2469 Injection, palonosetron hcl, 25 mcg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
J2405 Injection, ondansetron hydrochloride, per 1 mg
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96372 Injection of drug or substance under skin or into muscle
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99459 Pelvic exam
96417 Administration of additional new drug or substance into vein, 1 hour or less
36415 Insertion of needle into vein for collection of blood sample
A9573 Injection, gadopiclenol, 1 ml
96415 Administration of chemotherapy into vein, each additional hour
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3489 Injection, zoledronic acid, 1 mg
96375 Injection of additional new drug or substance into vein
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3475 Injection, magnesium sulfate, per 500 mg
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
36591 Collection of blood sample from implanted device
82044 Urine microalbumin (protein) analysis
71260 Ct scan of chest with contrast
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J7030 Infusion, normal saline solution , 1000 cc
J3490 Unclassified drugs
74177 Ct scan of abdomen and pelvis with contrast
96361 Infusion into a vein for hydration, each additional hour
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
84443 Blood test, thyroid stimulating hormone (tsh)
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96523 Irrigation of implanted venous access drug delivery device
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
58571 Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less
56820 Exam of external female genitals using an endoscope
82565 Blood creatinine level
38570 Biopsy and removal of lymph nodes of abdominal cavity using an endoscope
38900 Imaging of lymph nodes during surgery
96360 Infusion into a vein for hydration, 31-60 minutes
70553 Mri scan of brain before and after contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.